{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:46:06Z","timestamp":1762004766869},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T00:00:00Z","timestamp":1443744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.bjid.2015.08.011","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T00:11:24Z","timestamp":1445559084000},"page":"596-603","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Activity of ceftaroline and comparators against pathogens isolated from skin and soft tissue infections in Latin America \u2013 results of AWARE surveillance 2012"],"prefix":"10.1016","volume":"19","author":[{"given":"Daryl","family":"Hoban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Biedenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Sahm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edina","family":"Reiszner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Iaconis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2015.08.011_bib0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/ciu444","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Disease Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2015.08.011_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2015.08.011_bib0125","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa055356","article-title":"Methicillin-resistant S. aureus infections among patients in the emergency department","volume":"355","author":"Moran","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2015.08.011_bib0130","doi-asserted-by":"crossref","first-page":"iii35","DOI":"10.1093\/jac\/dkq302","article-title":"Complicated skin and soft tissue infection","volume":"65","author":"Dryden","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2015.08.011_bib0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MD.0b013e3181e8d635","article-title":"The role of \u03b2-hemolytic Streptococci in causing diffuse, nonculturable cellulitis","volume":"89","author":"Jeng","year":"2010","journal-title":"Medicine"},{"key":"10.1016\/j.bjid.2015.08.011_bib0140","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/1469-0691.12705","article-title":"New epidemiology of Staphylococcus aureus infection in Asia","volume":"20","author":"Chen","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2015.08.011_bib0145","doi-asserted-by":"crossref","first-page":"iv3","DOI":"10.1093\/jac\/dkq250","article-title":"The problem of complicated skin and skin structure infections: the need for new agents","volume":"65","author":"Moellering","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2015.08.011_bib0150","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1517\/14656566.2012.685718","article-title":"Carfaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection","volume":"13","author":"Casapao","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bjid.2015.08.011_bib0155","series-title":"Antibiotic resistance threats in the United States","author":"Centers for Disease Control and Prevention","year":"2013"},{"key":"10.1016\/j.bjid.2015.08.011_bib0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40121-013-0010-x","article-title":"Ceftaroline fosamil: a brief clinical review","volume":"2","author":"Shirley","year":"2013","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.bjid.2015.08.011_bib0165","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s40265-013-0075-6","article-title":"Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia","volume":"73","author":"Frampton","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.bjid.2015.08.011_bib0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bjid.2013.11.005","article-title":"Ceftaroline activity tested against contemporary Latin American bacterial pathogens [2011]","volume":"18","author":"Flamm","year":"2014","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2015.08.011_bib0175","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.bjid.2013.07.002","article-title":"Susceptibility rates in Latin American nations: report from a regional resistance surveillance program [2011]","volume":"17","author":"Jones","year":"2013","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2015.08.011_bib0180","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.diagmicrobio.2013.08.027","article-title":"Ceftaroline activity against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers [2009\u20132011]","volume":"78","author":"Pfaller","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2015.08.011_bib0185","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijantimicag.2012.12.013","article-title":"Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe [2010]","volume":"41","author":"Farrell","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bjid.2015.08.011_bib0190","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/jac\/dkm150","article-title":"In vitro activity of ceftaroline [PPI-0903M, T-91825] against bacteria with defined resistance mechanisms and phenotypes","volume":"60","author":"Mushtaq","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2015.08.011_bib0195","doi-asserted-by":"crossref","first-page":"iii45","DOI":"10.1093\/jac\/dkr098","article-title":"Review of ceftaroline fosamil microbiology: integrated FOCUS studies","volume":"66","author":"Critchley","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2015.08.011_bib0200","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2165\/11635660-000000000-00000","article-title":"Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections","volume":"72","author":"Lodise","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.bjid.2015.08.011_bib0205","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1093\/cid\/cis562","article-title":"Ceftaroline potency among 9 US census regions: report from the 2010 AWARE program","volume":"55","author":"Flamm","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2015.08.011_bib0210","unstructured":"Clinical Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standards \u2013 9th ed. CLSI document M07-A9. Wayne, PA 19087-1898 USA; 2012."},{"key":"10.1016\/j.bjid.2015.08.011_bib0215","series-title":"M100-S24. Performance standards for antimicrobial susceptibility testing; Twenty-Fourth Informational Supplement","author":"Clinical Laboratory Standards Institute","year":"2014"},{"key":"10.1016\/j.bjid.2015.08.011_bib0220","series-title":"Tigecycline FDA prescribing information","author":"Tygacil\u00ae","year":"2013"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867015001865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867015001865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T09:22:47Z","timestamp":1537262567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867015001865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1413867015001865"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2015.08.011","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of ceftaroline and comparators against pathogens isolated from skin and soft tissue infections in Latin America \u2013 results of AWARE surveillance 2012","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2015.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}